Publication | Closed Access

Efficacy and safety of idelalisib in combination with ofatumumab for previously treated chronic lymphocytic leukaemia: an open-label, randomised phase 3 trial

Hematological MalignancyLymphoid NeoplasiaChronic Lymphocytic LeukaemiaMedicineRandomised Phase 3ImmunologyClinical TrialsHematologyImmune Checkpoint InhibitorPharmacotherapyImmunotherapyOncologyHealth Sciences